Nasal therapeutic HPV vaccine could prevent cervical cancer
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
A nasal therapeutic vaccine for human papillomavirus (hpv) is being considered as a potential preventative measure for cervical cancer. The vaccine is administered nasally, suggesting an alternative delivery method to traditional vaccines. This vaccine may offer a new approach to preventing cervical cancer.
Full coverage
1
Science | AAAS·Nov 122
Oncology Central·Nov 183
Drug Target Review·Nov 174
Genetic Engineering and Biotechnology News·Nov 155
Science News·Dec 16
drugdiscoverytrends.com·Dec 87
American Association for Cancer Research (AACR)·Jan 248
National Geographic·Dec 2